GLP-1 Market
LLY $1351.12 ▼ -2.3% NVO $38.87 ▼ -1.4% PFE $27.54 ▼ -1.9% VKTX $25.84 ▼ -1.3% KLRA $11.58 ▼ -1.8% GPCR $17.12 ▼ -1.4% RHHBY $58.99 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Typhim Vi vaccine

Company
Swiss Federal Institute of Technology
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026

Trial details
  • Completed NCT NCT02429531

    Polysaccharide Antibody Response Study

    Not yet reported Universitaire Ziekenhuizen KU Leuven 200 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Specific Polysaccharide Antibody Deficiency
    View official trial listing →
  • Completed NCT NCT03312699

    Effects of Aging on Primary and Secondary Vaccine Responses

    Not yet reported Stanford University 54 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Influenza, Hepatitis A, Typhoid, Healthy Adults
    View official trial listing →
  • Completed NCT NCT03917654

    Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1301 participants Est. completion 2022-10-31 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT05919472

    Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women

    Not yet reported Nicole Stoffel 180 participants Est. completion 2024-07-16 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT06116669

    Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women

    Not yet reported Swiss Federal Institute of Technology 215 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.